COPD has long been managed as a condition to be controlled rather than meaningfully altered. That view is shifting. As research into airway biology has advanced, it has become clear that COPD is a heterogeneous disease, and that targeting the right inflammatory pathway in the right patient can produce outcomes that were not previously possible.Learn more about this episode: http://chroniclungdiseases.com/en/copd-biologic-therapy-practical-guideRESPIPLUS™ received support from Sanofi to develop an informative podcast series specifically tailored to COPD Biologics.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #copdbiologicsCOPD biologics, biologic therapy COPD, dupilumab COPD, COPD treatment, eosinophils COPD, COPD exacerbations, precision medicine COPD, targeted COPD therapy, COPD clinical practice, COPD biomarkers, COPD management, respiratory health, chronic lung disease, COPD physician guide, pulmonary medicine, MPOC biologiques, traitement MPOC, médecine de précision

For decades, COPD was treated as a single, uniform disease. That's changing. A new generation of targeted therapies is making it possible to match treatment to patient biology, and the results from recent clinical trials are giving clinicians reason for optimism.In this episode, Dr. MeiLan Han explores what biologics actually do in the context of COPD, how blood eosinophil levels guide patient selection, and what the BOREAS and NOTUS trials tell us about real-world outcomes. She also addresses the practical challenges of integrating biologics into clinical practice, from interpreting biomarker variability to setting honest expectations with patients.Learn more about this episode: http://chroniclungdiseases.com/en/copd-biologics-era-precision-medicineRESPIPLUS™ received support from Sanofi to develop an informative podcast series specifically tailored to COPD Biologics.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #copdbiologicsCOPD biologics, biologic therapy COPD, dupilumab COPD, COPD treatment, eosinophils COPD, COPD exacerbations, precision medicine COPD, targeted COPD therapy, COPD clinical practice, COPD biomarkers, COPD management, respiratory health, chronic lung disease, COPD physician guide, pulmonary medicine, MPOC biologiques, traitement MPOC, médecine de précision

Preventing respiratory infections requires preparation, collaboration, and community engagement. In this final episode of Season 7 of the eXpand podcast series, pharmacists Mike Boivin and Amy Lamb bring together key insights from the series to highlight practical strategies for prevention and community-centred care.In the concluding episode of the series, Mike Boivin and Amy Lamb focus on actionable strategies to reduce respiratory infection risks in Indigenous and remote communities.The discussion explores proactive planning for respiratory illness seasons, improving testing and treatment pathways, and strengthening partnerships between healthcare providers and communities. The episode emphasizes the importance of trust, cultural safety, and collaborative health leadership.Learn more about this episode: http://chroniclungdiseases.com/en/preventing-respiratory-infections-indigenous-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19respiratory infections Indigenous communities,COVID-19 Indigenous health Canada,COPD Indigenous populations,antiviral access remote communities,vaccination Indigenous communities,RSV First Nations,respiratory health Métis Inuit,pharmacist Indigenous care,culturally safe healthcare,COPD comorbidities,influenza prevention remote Canada,Expand Podcast Respiplus,respiratory podcast healthcare professionals,COVID-19 antiviral treatment,Indigenous health equity

Early testing and treatment can make a critical difference in respiratory infections. In this episode of the eXpand podcast series, pharmacists Mike Boivin and Amy Lamb discuss the importance of rapid access to antivirals and timely care pathways in Indigenous and remote communities.This episode examines how early diagnosis and rapid treatment can improve outcomes in respiratory infections such as COVID-19 and influenza.Mike Boivin and Amy Lamb discuss barriers to testing and treatment in remote settings, the importance of culturally responsive communication, and how community-led pathways can support earlier intervention. The episode introduces the “Life Pathway” model, a practical framework for improving access to care.Learn more about this episode: http://chroniclungdiseases.com/en/early-treatment-respiratory-infections-remote-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19

Vaccination remains one of the most important tools for preventing severe respiratory infections. In this episode of the eXpand Podcast, pharmacists Mike Boivin and Amy Lamb explore vaccination strategies in Indigenous communities and the importance of culturally safe healthcare approaches.This episode focuses on vaccines as a key strategy to reduce the burden of respiratory infections such as COVID-19, influenza, RSV, and pneumococcal disease.Mike Boivin and Amy Lamb discuss the realities of vaccine delivery in remote communities, including logistical challenges and the importance of culturally respectful engagement. The conversation highlights how trust, partnership, and community leadership are essential for effective vaccination initiatives.Learn more about this episode: http://chroniclungdiseases.com/en/respiratory-infection-risks-indigenous-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19

Respiratory infections such as COVID-19, influenza, and RSV do not occur in isolation. In this episode of the RESPIPLUS podcast series, pharmacists Mike Boivin and Amy Lamb explore how chronic conditions, social determinants of health, and healthcare access barriers shape respiratory illness outcomes in Indigenous communities across Canada.This episode takes a deeper look at why respiratory infections can have different impacts across populations. The discussion focuses on the intersection of chronic disease, social determinants of health, and healthcare access.Mike Boivin and Amy Lamb highlight how conditions such as diabetes, COPD, and cardiovascular disease can increase vulnerability to respiratory infections. They also explore how trust, relationship-building, and community leadership play a critical role in improving health outcomes.Learn more about this episode: http://chroniclungdiseases.com/en/respiratory-infection-risks-indigenous-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19

This opening episode introduces a series focused on respiratory infectious diseases and their impact in Indigenous communities across Canada. Pharmacists Mike Boivin and Amy Lamb explore how systemic barriers, healthcare access challenges, and social determinants of health influence outcomes during respiratory illness seasons.The discussion highlights both the structural issues affecting healthcare delivery and the resilience of Indigenous communities. The episode also sets the stage for future conversations about comorbidities, vaccination strategies, and practical prevention approaches.Learn more about this episode: http://chroniclungdiseases.com/en/respiratory-infections-indigenous-communitiesThis podcast is produced by RESPIPLUS™ with support from Pfizer to raise awareness about COVID-19 and improve access to care across Canada.This podcast series was developed with the valuable collaboration of organizations committed to improving patient care:- Indigenous Pharmacy Professionals of Canada: https://indigenouspharmacy.ca/- Lung Saskatchewan: https://www.lungsask.ca/The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #covid19

Pulmonary Arterial Hypertension: Early Diagnosis and Hope for PatientsPulmonary arterial hypertension is rare, serious, and often missed. Yet with early diagnosis and coordinated care, many patients can live well for years.In Episode 3 of the RESPIPLUS podcast series, Dr. Jean Bourbeau is joined by cardiologist Dr. Nathan Brunner to discuss pulmonary arterial hypertension through a cardiology lens. The episode focuses on why early detection matters, how multidisciplinary teams improve care, and what happens when diagnosis is delayed.Dr. Brunner also shares insights from his research on healthcare access, including rural and Indigenous populations, and outlines emerging opportunities in diagnostics and therapy that may shape the future of pulmonary hypertension care in Canada.This podcast is produced by RESPIPLUS™ with support from Merck to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #pulmonaryarterialhypertension #pulmonaryhypertension

Pulmonary Hypertension in Canada: Awareness, Diagnosis, and ProgressPulmonary hypertension remains widely misunderstood, yet early recognition can profoundly change patient outcomes. In this episode, we explore how awareness, guidelines, and multidisciplinary care are reshaping pulmonary hypertension care in Canada.About this episodeIn Episode 2 of the RESPIPLUS podcast series, Dr. Jean Bourbeau speaks with Dr. Sanjay Mehta about the realities of pulmonary hypertension and pulmonary arterial hypertension in clinical practice. The conversation unpacks why diagnosis is often delayed, how classification informs care, and why multidisciplinary expertise is essential for optimal management.Dr. Mehta also reflects on how advances in treatment have transformed survival and quality of life for many patients, while highlighting ongoing gaps in access to care, particularly for people living outside major urban centres. The episode emphasizes the role of research, guidelines, and patient advocacy in improving outcomes across Canada.This podcast is produced by RESPIPLUS™ with support from Merck to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #pulmonaryarterialhypertension #pulmonaryhypertension

In this Season 6 episode, we sit down with Jamie Myrah, Executive Director of the Pulmonary Hypertension Association of Canada. Interviewed by Dr. Jean Bourbeau, Jamie explores the complexity of pulmonary hypertension with a focus on pulmonary arterial hypertension. She explains what PAH is, why it is often difficult to diagnose, and how delays affect patients emotionally and socially.From her front-line perspective, Jamie highlights gaps in the healthcare system, the impact of specialized clinics, and how patient stories fuel advocacy, research, and access to treatments. The conversation underscores the urgent need for better diagnostic tools and the power of community support for people living with this rare disease.This podcast is produced by RESPIPLUS™ with support from Merck to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #pulmonaryarterialhypertension #pulmonaryhypertension